Drug Trial Radar · NCT04849741
A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD)
Last checked: Nov 19, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
54
Actual
Start
Jun 1, 2021
Primary completion
Aug 22, 2025
Study completion Jul 2034
Sponsor
- Lead sponsor
- Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
- Sponsor type
- Industry
- First posted
- Apr 19, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of zilganersen (ION373) in improving or stabilizing gross motor function across the full range of affected domains in patients with AxD.
Conditions
- Alexander Disease
Interventions
zilganersenDrug
zilganersen will be administered by ITB injection.
PlaceboDrug
zilganersen-matching placebo will be administered by ITB injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change from Baseline in the 10-Meter Walk Test (10MWT)Time frame: Baseline and Week 61
Locations
13 sites in 8 countries. Site status is shown where the registry gives one.
Lucile Packard Children's Hospital Stanford
Palo Alto, California
Children's Hospital of Atlanta
Atlanta, Georgia
Massachusetts General Hospital
Boston, Massachusetts
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Murdoch Children's Research Institute
Parkville, Victoria, Australia
McGill University Health Centre
Montreal, Quebec, Canada
Pediatric Neurology Institute, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Ospedale dei Bambini Vittore Buzzi
Milan, Italy
Ospedale Pediatrico Bambino Gesù
Roma, Italy
National Center of Neurology and Psychiatry
Tokyo, Kodaira-shi, Japan
Amsterdam Universitair Medische Centra - Academisch Medisch Centrum
Amsterdam, North Holland, Netherlands
University College London Hospitals NHS Foundation Trust
London, United Kingdom
Great Ormond Street Hospital for Children NHS Foundation Trust
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.